Committee Composition

  Audit Nominating and Governance Compensation
Jack Goldstein, Ph.D Chairman of the Board Member of Audit Committee Member of Nominating and Governance Committee Member of Compensation Committee
Scott Cormack      
Neil James Clendeninn, Ph.D, MD   Member of Nominating and Governance Committee Committee Chair for Compensation Committee
Martin Mattingly, PharmD Member of Audit Committee   Member of Compensation Committee
Stewart Parker Member of Audit Committee Committee Chair for Nominating and Governance Committee  
David Smith Committee Chair for Audit Committee Member of Nominating and Governance Committee  
Director

David V. Smith, has served as a director of the Company since August 2010. Mr. Smith has more than 30 years of financial and operational management experience, and has held leadership positions in the biotechnology industry for more than two decades. He was recently appointed Chief Operating Officer at IntegenX. Prior to IntegenX, Mr. Smith served as the Executive Vice president and Chief Financial Officer of Thoratec Corporation. Prior to joining Thoratec in 2006, Mr. Smith served as Vice President and Chief Financial Officer of Chiron Corporation. Prior to Chiron, Mr. Smith was the Vice President of Finance and Chief Financial Officer at Anergen Incorporated. He has also served in various financial management positions with Genentech, Inc., both in the United States and Europe, and previously held finance positions at Syntex Corporation and IBM Corporation. Mr. Smith earned a B.A. in Economics and History from Willamette University and an M.B.A. in Finance from Golden Gate University. Previously, he was a member of the board of directors and chair of the audit committee of Perlegen Sciences, Inc.
Chair of the Board = Chair of the Board Committee Chair = Chair Committee Member = Member